Immunocore Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	467.71	455.73	442.63	402.47	321.62
Short-Term Investments	396.44	364.65	-	-	-
Cash & Short-Term Investments	864.15	820.38	442.63	402.47	321.62
Cash Growth	5.34%	85.34%	9.98%	25.14%	81.35%
Accounts Receivable	73.98	63.01	52.09	33.58	20.56
Other Receivables	1.82	-	-	-	13.02
Total Trade Receivables	75.79	63.01	52.09	33.58	33.58
Inventory	6.74	5.45	4.5	0.69	-
Other Current Assets	50.06	41.03	29.6	37.23	-
Total Current Assets	996.74	929.86	528.82	473.98	355.2
Net Property, Plant & Equipment	50.25	47.74	42.74	38.78	42.64
Other Long-Term Assets	20.28	31.91	25.45	14.01	10.15
Total Assets	1,067	1,010	597	526.76	408
Accounts Payable	24.36	25.1	17.8	14.45	-
Accrued Expenses	219.74	185.53	119.84	76.75	-
Current Portion of Leases	2.01	1.55	1.39	1.88	1.7
Unearned Revenue	0.58	-	-	7.76	33.06
Total Current Liabilities	246.7	212.18	139.02	100.84	34.75
Long-Term Debt	393.13	391.01	48.01	47.81	50.33
Long-Term Leases	41.56	40.16	35.61	31.76	34.28
Other Long-Term Liabilities	4.86	5.43	5.52	7.46	8.66
Total Long-Term Liabilities	439.54	436.61	89.14	87.02	93.27
Total Liabilities	686.24	648.79	228.16	187.86	176.07
Common Stock	0.14	0.14	0.14	0.13	0.12
Additional Paid-in Capital	1,240	1,190	1,150	1,083	-
Accumulated Other Comprehensive Income	-28.08	-33.76	-36.26	-54.67	-
Retained Earnings	-831.28	-795.76	-744.67	-689.39	-650.84
Shareholders' Equity	381.03	360.72	368.84	338.9	231.93
Total Liabilities & Equity	1,067	1,010	597	526.76	408
Total Debt	436.69	432.72	85.01	81.45	86.31
Net Cash (Debt)	427.47	387.65	357.62	321.02	235.31
Net Cash Growth	10.27%	8.40%	11.40%	36.42%	161.46%
Net Cash Per Share	8.49	7.75	7.32	7.02	5.54
Book Value	381.03	360.72	368.84	338.9	231.93
Book Value Per Share	7.57	7.22	7.54	7.41	5.46
Tangible Book Value	381.03	360.72	368.84	338.9	231.93
Tangible Book Value Per Share	7.57	7.22	7.54	7.41	5.46

Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q